Founded by Bernie Schaeffer, we provide stock news, options insights, and premium trading services to options traders

 

BACKED BY 170+ YEARS OF MARKET EXPERTISE

Get Schaeffer’s market outlook every Monday, straight to your inbox.

 

 
 
 
 
 
 
 
 
X
Schaeffer’s Midday Market Check Daily Newsletter
Wall Street is firmly higher Friday, heading for solid weekly wins. The Dow Jones Industrial Average (DJI), Nasdaq Composite (IXIC), and S&P 500 Index (SPX) all sport significant intraday leads, ... Wall Street is firmly higher Friday, heading for solid weekly wins. The Dow Jones Industrial Average (DJI), Nasdaq Composite (IXIC), and S&P 500 Index (SPX) all sport significant intraday leads, with the latter two on pace for their fifth-straight daily gains. Small caps are also higher, with t ... Keep Reading
Restoration Hardware stock, RH stock, RH stock price
Shares of RH (NYSE:RH), formerly known as Restoration Hardware, are soaring today, up 19.2% at $305.72 at last glance, after the company's better-than-expected second-quarter earnings and revenue. Acc ... Shares of RH (NYSE:RH), formerly known as Restoration Hardware, are soaring today, up 19.2% at $305.72 at last glance, after the company's better-than-expected second-quarter earnings and revenue. According to the equity, demand for the furniture retailer's products rose 7% in the quarter, with CEO ... Keep Reading
Stock growth increasing
On finance Twitter, FinTwit for short, Cathie Wood's ARK Innovation ETF (ARKK) gets a lot of flack, some of it rightfully so. It's not 2021 anymore; the high interest-rate environment coupled and less ... On finance Twitter, FinTwit for short, Cathie Wood's ARK Innovation ETF (ARKK) gets a lot of flack, some of it rightfully so. It's not 2021 anymore; the high interest-rate environment coupled and less risk appetite is not very conducive to the growth stocks that ran rampant three years ago. ARKK did ... Keep Reading
AstraZeneca stock, AZN stock, AZN stock news, AZN vaccine
Biopharmaceutical stock AstraZeneca PLC (NASDAQ:AZN) is 1.3% lower before the open, after a bear note from Deutsche Bank. The analyst downgraded AZN to "sell" from "hold" and lowered its price target, ... Biopharmaceutical stock AstraZeneca PLC (NASDAQ:AZN) is 1.3% lower before the open, after a bear note from Deutsche Bank. The analyst downgraded AZN to "sell" from "hold" and lowered its price target, pointing to the company's results from a lung cancer trial that showed its experimental precision d ... Keep Reading